ePatientFinder's Clinical Trial Thought Leadership To Be Highlighted at MAGI East and DIA
Senior VP Greg Sweatt to discuss expanding patient access to cutting-edge research by leveraging EHR data and the physician-patient relationship
AUSTIN, Texas, May 22, 2017 /PRNewswire/ -- ePatientFinder®, the leader in EHR-driven clinical trial site optimization and patient identification, announces that two leading life sciences conferences have selected ePatientFinder's Co-Founder and Senior Vice President of Life Sciences Greg Sweatt as a featured speaker.
Sweatt will be featured as a thought leader in the following educational panels and sessions:
| • |
MAGI's Clinical Research Conference−2017 East, taking place this week, May 21−24 in Philadelphia |
| SESSION DETAILS: |
|
| WHEN: Today, May 22, 11:30−12:15 ET |
|
| TITLE: Patient-Centric Clinical Trials: A Panel Discussion |
|
| DESCRIPTION: Panelists will discuss "What's Desirable and What's Practical" when it comes to patient centricity in clinical trials. Sweatt joins the following panelists in a thought-provoking discussion about this important topic: |
|
| • Joan Chambers - Chief Operating Officer—CenterWatch |
|
| • Lisa Dilworth - Director of Therapeutic Expertise, Rare Diseases—PRA Health Sciences |
|
| • Ashley Tointon - Sr. Patient Recruitment Strategist—Boehringer Ingelheim Pharmaceuticals |
|
| • |
DIA 2017, taking place June 18-22 in Chicago |
| SESSION DETAILS: |
|
| WHEN: June 20, 2 pm CT |
|
| TITLE: If You See Something (About a Clinical Trial), Do You Say Something (to Your Doctor?) |
|
| DESCRIPTION: This session will delve into the newest innovations and ideas in patient enrollment and participating in clinical trials. Sweatt's talk focuses on: Leveraging EHR Data and the Physician-Patient Relationship to Raise Patient Awareness of Trials and Accelerate Recruitment. His co-presenters for this session include: |
|
| • Tyler Ludlow, MBA, Senior Decision Scientist, Eli Lilly Company |
|
| • Candice E Junge, PhD, Development Design Director, Amgen |
|
| EXHIBIT HALL: ePatientFinder also will be exhibiting at DIA 2017—Booth #1758. |
Tom Dorsett, CEO and co-founder of ePatientFinder, said the company's speaking engagements are gratifying because they reflect the life science industry's recognition of ePatientFinder's leadership in the clinical trial space.
"It's extremely important for us to not only offer a game-changing patient identification and enrollment solution, but also to be actively engaged in the dialogue about where the market is now and where it needs to go in the future," Dorsett said. "Our goal is to more quickly and efficiently make more trials available to qualified patients, which benefits patients, providers, sponsors and contract research organizations [CROs], while also keeping clinical trials on schedule and on budget."
ePatientFinder's Clinical Trial Exchange™ leverages the power of electronic health record (EHR) data analytics and the physician-patient relationship to identify patients who are eligible to participate in clinical trials. In addition to increasing efficiencies, empowering physicians to match their own patients to clinical trials strengthens the physician-patient relationship. ePatientFinder partners with most major EHR vendors, and recently worked with Allscripts to develop GeoPrecise, a solution that makes using EHR data to identify patients for clinical trials more streamlined.
About ePatientFinder®
ePatientFinder®, based in Austin, Texas, is the only company that provides physicians and clinical trial sites with a secure technology platform that allows them to compliantly leverage EHR data and make it actionable. By tapping into the trusted physician-patient relationship, ePatientFinder produces the highest quality referrals in the business, which in turn help clinical trials get populated more quickly and cost effectively than ever before. With ePatientFinder, physicians and EHR providers develop additional revenue streams with little change to their current activities, and patient satisfaction increases dramatically with access to the advanced care that is only available through clinical trials. Learn more at www.epatientfinder.com and follow @ePatientFinder on Twitter.
Media Contact
Amendola Communications for ePatientFinder:
Tara Stultz, 440.225.9595, [email protected]
SOURCE ePatientFinder
Share this article